Federal Register: October 28, 2009 (Volume 74, Number 207)
DOCID: fr28oc09-109 FR Doc E9-25884
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
DOCID: fr28oc09-109
SUBJECT CATEGORY:
Manufacturer of Controlled Substances; Notice of Application
DOCUMENT SUMMARY:
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 16, 2009, American
Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146,
made application by renewal to the Drug Enforcement Administration
(DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Gamma Hydroxybutyric Acid (2010)........... I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Dimethyltryptamine (7435).................. I
1[1(2Thienyl)cyclohexyl]piperidine......
(7470)..................................... I
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Metazocine (9240).......................... II
Dextropropoxyphene, bulk (nondosage forms) II
(9273).
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Phenazocine (9715)......................... II
Fentanyl (9801)............................ II
The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research.
Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 28, 2009.
Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925884 Filed 102709; 8:45 am]
BILLING CODE 441009P
SUMMARY:
Manufacturer of Controlled Substances; Applications
DOCUMENT BODY 2:
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 16, 2009, American
Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146,
made application by renewal to the Drug Enforcement Administration
(DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Gamma Hydroxybutyric Acid (2010)........... I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Dimethyltryptamine (7435).................. I
1[1(2Thienyl)cyclohexyl]piperidine......
(7470)..................................... I
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Metazocine (9240).......................... II
Dextropropoxyphene, bulk (nondosage forms) II
(9273).
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Phenazocine (9715)......................... II
Fentanyl (9801)............................ II
The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research.
Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 28, 2009.
Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925884 Filed 102709; 8:45 am]
BILLING CODE 441009P